Marcel Rys
Overview
Explore the profile of Marcel Rys including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kolenda T, Rys M, Guglas K, Teresiak A, Blizniak R, Mackiewicz J, et al.
Arch Med Sci
. 2021 Aug;
17(4):1006-1015.
PMID: 34336028
Introduction: Long non-coding RNAs (lncRNAs), a class of regulatory RNA molecules, are over 200 nucleotides long and could be used as a new potential biomarker, but their detection methods such...
2.
Kolenda T, Rutkowski P, Michalak M, Kozak K, Guglas K, Rys M, et al.
Oncotarget
. 2019 Jun;
10(39):3879-3893.
PMID: 31231466
Long non-coding RNAs (lncRNA) are dysregulated in many cancer types. Abnormal baseline levels of these lncRNAs display diagnostic and prognostic potential in cancer patients. The aim of this study was...
3.
Guglas K, Bogaczynska M, Kolenda T, Rys M, Teresiak A, Blizniak R, et al.
Contemp Oncol (Pozn)
. 2018 Feb;
21(4):259-266.
PMID: 29416430
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cause of cancer mortality in the world. Some progress has been made in the therapy of HNSCC, however...
4.
Kolenda T, Guglas K, Rys M, Bogaczynska M, Teresiak A, Blizniak R, et al.
Rep Pract Oncol Radiother
. 2017 Aug;
22(5):378-388.
PMID: 28794691
Head and neck squamous cell carcinoma (HNSCC) are one of the worst prognosis cancers with high mortality of patients. The treatment strategy is primarily based on surgery and radiotherapy but...